PAD 214 (Naratriptan 1 mg)
Pill imprint PAD 214 has been identified as Naratriptan hydrochloride 1 mg.
Naratriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Naratriptan 1 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 1 mg
- Prescription only
More about naratriptan
- Other brands: Amerge
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.